Cordlife Group Limited (CLIFF)
USD 0.12
(-8.61%)
USD 0.12
(-8.61%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 797 Thousand SGD | -41.48% |
| 2022 | 1.36 Million USD | 28.7% |
| 2021 | 1.05 Million SGD | -15.69% |
| 2020 | 1.25 Million SGD | 25.68% |
| 2019 | 998.77 Thousand SGD | -26.45% |
| 2018 | 1.35 Million SGD | 8.21% |
| 2017 | 1.25 Million SGD | -1.88% |
| 2016 | 1.27 Million SGD | 21.0% |
| 2015 | 1.05 Million SGD | 67.24% |
| 2014 | 632 Thousand SGD | -2.01% |
| 2013 | 645 Thousand SGD | 48.28% |
| 2012 | 435 Thousand SGD | 4.32% |
| 2011 | 417 Thousand SGD | 82.89% |
| 2010 | 228 Thousand SGD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | 1.11 Million SGD | 9.95% |
| 2023 Q2 | 824.83 Thousand USD | -26.09% |
| 2023 Q4 | 603.64 Thousand USD | -24.26% |
| 2023 FY | 797 Thousand SGD | -41.48% |
| 2023 Q3 | 797 Thousand SGD | -3.37% |
| 2022 Q1 | 1.47 Million SGD | 2.94% |
| 2022 FY | 1.36 Million USD | 28.7% |
| 2022 Q4 | 1.01 Million USD | -25.48% |
| 2022 Q3 | 1.36 Million SGD | 28.86% |
| 2022 Q2 | 1.05 Million SGD | -28.1% |
| 2021 Q1 | 1.28 Million SGD | -22.78% |
| 2021 Q3 | 1.42 Million SGD | 11.48% |
| 2021 Q4 | 1.42 Million SGD | 0.0% |
| 2021 FY | 1.05 Million SGD | -15.69% |
| 2021 Q2 | 1.28 Million SGD | 0.0% |
| 2020 Q2 | 1.75 Million SGD | 0.0% |
| 2020 Q3 | 1.65 Million SGD | -5.52% |
| 2020 Q4 | 1.65 Million SGD | 0.0% |
| 2020 FY | 1.25 Million SGD | 25.68% |
| 2020 Q1 | 1.75 Million SGD | 30.75% |
| 2019 Q4 | 1.34 Million SGD | 2.75% |
| 2019 Q1 | 1.25 Million SGD | -7.51% |
| 2019 FY | 998.77 Thousand SGD | -26.45% |
| 2019 Q2 | 1.27 Million SGD | 1.59% |
| 2019 Q3 | 1.3 Million SGD | 2.43% |
| 2018 Q2 | 1.25 Million SGD | -13.86% |
| 2018 FY | 1.35 Million SGD | 8.21% |
| 2018 Q4 | 1.35 Million SGD | 6.85% |
| 2018 Q3 | 1.27 Million SGD | 1.27% |
| 2018 Q1 | 1.45 Million SGD | -0.21% |
| 2017 Q4 | 1.46 Million SGD | 5.49% |
| 2017 FY | 1.25 Million SGD | -1.88% |
| 2017 Q3 | 1.38 Million SGD | 8.21% |
| 2017 Q2 | 1.27 Million SGD | 4.49% |
| 2017 Q1 | 1.22 Million SGD | -10.85% |
| 2016 Q4 | 1.37 Million SGD | 21.94% |
| 2016 FY | 1.27 Million SGD | 21.0% |
| 2016 Q3 | 1.12 Million SGD | 6.53% |
| 2016 Q2 | 1.05 Million SGD | 26.74% |
| 2016 Q1 | 834 Thousand SGD | -7.64% |
| 2015 FY | 1.05 Million SGD | 67.24% |
| 2015 Q4 | 903 Thousand SGD | 20.08% |
| 2015 Q3 | 752 Thousand SGD | -11.63% |
| 2015 Q2 | 851 Thousand SGD | 11.39% |
| 2015 Q1 | 764 Thousand SGD | -2.05% |
| 2014 Q1 | 648 Thousand SGD | 33.06% |
| 2014 Q4 | 780 Thousand SGD | 23.22% |
| 2014 Q3 | 633 Thousand SGD | -1.86% |
| 2014 Q2 | 645 Thousand SGD | -0.46% |
| 2014 FY | 632 Thousand SGD | -2.01% |
| 2013 Q3 | 440 Thousand SGD | 1.15% |
| 2013 Q4 | 487 Thousand SGD | 10.68% |
| 2013 FY | 645 Thousand SGD | 48.28% |
| 2013 Q1 | 233 Thousand SGD | -30.24% |
| 2013 Q2 | 435 Thousand SGD | 86.7% |
| 2012 Q1 | 373 Thousand SGD | 0.0% |
| 2012 FY | 435 Thousand SGD | 4.32% |
| 2012 Q2 | 417 Thousand SGD | 11.8% |
| 2012 Q4 | 334 Thousand SGD | 9.15% |
| 2012 Q3 | 306 Thousand SGD | -26.62% |
| 2011 Q2 | 228 Thousand SGD | 0.0% |
| 2011 FY | 417 Thousand SGD | 82.89% |
| 2010 FY | 228 Thousand SGD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -110.29% |
| Arrayit Corporation | 464.19 Thousand USD | -71.696% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -5.284% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 33517.191% |
| DermTech, Inc. | 1 Million USD | 20.618% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 75.842% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 12.353% |
| iMD Companies, Inc. | 38.31 Thousand USD | -1980.071% |
| IDenta Corp. | 442.28 Thousand USD | -80.202% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 35.045% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -388.552% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -1.658% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 212633.333% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -70.018% |
| PharmChem, Inc. | 391.93 Thousand USD | -103.349% |
| Proteome Sciences plc | 1.06 Million USD | 25.2% |
| Response Genetics, Inc | 133 Thousand USD | -499.248% |
| Rennova Health, Inc. | 242.64 Thousand USD | -228.463% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -978.528% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -733.499% |
| Todos Medical Ltd. | 1.02 Million USD | 21.939% |